Evaluation of Epstein-Barr Virus Latent Membrane Protein 2 Specific T-Cell Receptors Driven by T-Cell Specific Promoters Using Lentiviral Vector
Transduction of latent membrane protein 2 (LMP2)-specific T-cell receptors into activated T lymphocytes may provide a universal, MHC-restricted mean to treat EBV-associated tumors in adoptive immunotherapy. We compared TCR-specific promoters of distinct origin in lentiviral vectors, that is, Vβ6.7,...
Saved in:
Main Authors: | Dongchang Yang, Qing Shao, Hua Sun, Xiaoxin Mu, Yun Gao, Runqiu Jiang, Jiajie Hou, Kun Yao, Yun Chen, Beicheng Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2011/716926 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing
by: Jennifer J. Labisch, et al.
Published: (2025-01-01) -
Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma
by: Xintao Jia, et al.
Published: (2021-01-01) -
Korelasi antara Latent Membrane Protein-1 Virus Epstein-Barr dengan P53 pada Karsinoma Nasofaring (Penelitian Lanjutan)
by: Yenita ., et al.
Published: (2012-07-01) -
Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
by: Inès Dufait, et al.
Published: (2012-01-01) -
Macular Amyloidosis and Epstein-Barr Virus
by: Yalda Nahidi, et al.
Published: (2016-01-01)